# Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

> **NCT00511849** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 43 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** carboplatin + SU011248 (sunitinib) + paclitaxel

## Key facts

- **NCT ID:** NCT00511849
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2010-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511849, "Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00511849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*